What's more, the data demonstrated early Victoza use showed promise at improving the function of insulin-producing beta cells, when compared with turning to the drug later in the course of treatment.

Victoza (liraglutide) solution for injection is prescribed to help manage blood sugar and reduce major heart-related risks. Victoza is not safe to use while pregnant and may not be safe to use ...

GLP-1 drugs were also associated with a slight increase in risk for kidney cancer. The increase was not statistically ...

Victoza, known generically as liraglutide, treats adults with type 2 diabetes. It is one of Novo's biggest sellers, with global sales of 2.1 billion Danish crowns ($370 million) in the fourth ...

With the unknown of long-term use of Victoza and thyroid malignancies, the FDA mandated that Novo establish a 15-year cancer registry to monitor the rate of medullary thyroid cancer in the U.S.

Victoza and Byetta both have potential side effects which include stomach pain, nausea and vomiting. Not recommended for use in type 1 diabetes It should be noted that Victoza, Byetta and Januvia have ...

Québec Becomes First Province to Add Victoza® to the Drug Benefit Formulary* for the Treatment of Type 2 Diabetes MISSISSAUGA, ON, June 4, 2014 /CNW/ - Novo Nordisk today announces that the ...

She weighed 209 pounds at the time and was prediabetic. The doctor told her she had to get down to 165 pounds and was prescribed Victoza to manage her prediabetic condition. She never imagined it ...

Nevertheless, approval of Victoza 1.2mg for NHS use is “good news” for healthcare professionals and their patients, according to Professor Anthony Barnett, Professor of Medicine, Consultant Physician ...

Novo Nordisk has posted another healthy set of figures for the first nine months of the year this morning, helped by a good start for its new diabetes drug Victoza. Net profit climbed 24% to 10.46 ...

Novo Nordisk has received positive CHMP decisions to expand the use of 2 of its products for type 2 diabetes. Tresiba can now be used with GLP-1 agonists such as Victoza and vice versa.

Novo Nordisk's big new drug hope Victoza has been recommended for limited use on Britain's state-run health service as a treatment for diabetes, the Danish drugmaker said on Monday.